Hikma Pharmaceuticals (MEX:HIKN) Volatility: N/A% (As of Jun. 29, 2026)


MEX:HIKN Hikma Pharmaceuticals PLC MEX:HIKN
80 GF Score
Price MXN307.48
GF Value MXN422.96
! 5 Warning Signs
View Full Analysis

What is Hikma Pharmaceuticals Volatility?

Hikma Pharmaceuticals MEX:HIKN 80 Volatility is N/A% as of Jun. 29, 2026. GuruFocus rates MEX:HIKN with a GF Score™ of 80/100 and a GF Value™ of MXN422.96. The stock has 5 warning signs investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

Hikma Pharmaceuticals does not have enough data to calculate Volatility.

Hikma Pharmaceuticals  (MEX:HIKN) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Hikma Pharmaceuticals Volatility Related Terms

MEX:HIKN
80GF Score
Hikma Pharmaceuticals PLC MEX:HIKN
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hikma Pharmaceuticals  (MEX:HIKN) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * √12
=√ 1/(n-1) ∑(Ri - R')^2 * √12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of N/A% mean?
Hikma Pharmaceuticals (MEX:HIKN) has a Volatility of N/A% as of Jun. 29, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Hikma Pharmaceuticals and its competitors.
Is Hikma Pharmaceuticals' Volatility too high?
Hikma Pharmaceuticals' current Volatility is N/A%. Overall, Hikma Pharmaceuticals has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Hikma Pharmaceuticals' Volatility compare to ZTS and UTHR?
Hikma Pharmaceuticals' Volatility of N/A% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Drug Manufacturers company?
A good Volatility depends on the Drug Manufacturers industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Hikma Pharmaceuticals and its competitors. Hikma Pharmaceuticals's current Volatility is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hikma Pharmaceuticals stock overvalued right now?
Hikma Pharmaceuticals (MEX:HIKN) has a current Volatility of N/A%. The stock's GF Value™ is MXN422.96, compared to a current price of MXN307.48 — trading 27.3% below its estimated fair value. The current Volatility is N/A%. Hikma Pharmaceuticals' overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For Hikma Pharmaceuticals (MEX:HIKN), the current Volatility is N/A% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hikma Pharmaceuticals (MEX:HIKN) Overvalued in 2026?

Based on GuruFocus' analysis, Hikma Pharmaceuticals stock appears to be undervalued. The current stock price of MXN307.48 is trading 27.3% below its estimated GF Value™ of MXN422.96.

Key valuation signals for MEX:HIKN:

  • Volatility: N/A%
  • GF Value™: MXN422.96 vs. price of MXN307.48 (27.3% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the MEX:HIKN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hikma Pharmaceuticals Business Description

Address 10 Portman Square, London, GBR, W1H 6AZ
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, Rx, and branded. The majority of the company's revenue is generated from its injectables segment, which supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue-generating market, followed by the Middle East and North Africa, the United Kingdom, Europe, and the rest of the world.
80GF Score

Get the complete analysis for MEX:HIKN

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN307.48
Price
MXN422.96
GF Value